Month: April 2022

Skylight Health Research has been selected to participate in 10 clinical research studies since its launch TORONTO, April 29, 2022 (GLOBE NEWSWIRE) — Skylight Health Group Inc. (NASDAQ:SLHG;TSXV:SLHG (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today provides an update on the status of the Company’s research program; Skylight Health Research.In April 2021, Skylight Health Research announced its partnership with ClinEdge to launch formal clinical research studies into its practices; Since inception, Skylight Health Research has been awarded ten (10) clinical studies and has completed two (2) to-date; Total revenue earned through clinical studies in 2021, $300,000, has already been surpassed in 2022, and is expected to quadruple by the end of this year; The progress since...

Not for dissemination in the United States or for distribution to U.S. Newswire Services VANCOUVER, British Columbia, April 29, 2022 (GLOBE NEWSWIRE) — Candente Copper Corp. (TSX:DNT, BVL:DNT, US:CCOUF) (“Candente Copper” or the “Company”) is pleased to advise that the Company has arranged a bridge loan in the aggregate principal amount of CDN$1 million from an arm’s length individual investor (the “Lender”) for a twelve-month term at 10% to be repaid on maturity. “This bridge loan was organized to allow sufficient time to explore several financing options that have been presented to the Company. Over the course of the next several weeks, Candente Copper and its advisors will assess and evaluate the financing offers received to date,” states Joanne Freeze, Company President and CEO. “The results of the recently published...

NEW HAMPTON, N.Y., April 29, 2022 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today first quarter net earnings of $28.9 million for 2022, compared to net earnings of $23.4 million for the first quarter 2021. Quarterly adjusted net earnings(a) were $33.4 million, compared to $28.4 million in the prior year quarter. Quarterly adjusted EBITDA(a) was $53.6 million, compared to $45.7 million in the prior year quarter. First Quarter 2022 Financial Highlights:Record net sales of $228.9 million, an increase of 23.3% compared to the prior year quarter with quarterly double-digit sales growth in all three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. Record adjusted EBITDA was $53.6 million, an increase of 17.2% from the prior year. GAAP net earnings were $28.9 million, an...

NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Sekur Private Data Ltd. (CSE: SWIS; OTCQX: SWISF), a cybersecurity and Internet privacy provider of Swiss hosted solutions for secure communications and secure data management, has qualified to trade on the OTCQX® Best Market. Sekur Private Data Ltd. upgraded to OTCQX from the OTCQB® Venture Market. Sekur Private Data Ltd. begins trading today on OTCQX under the symbol “SWISF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX, companies must meet high financial standards,...

HOUSTON, April 29, 2022 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the presentation of two poster abstracts at the upcoming American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, to be held in-person on June 3-7, 2022 in Chicago, Illinois. Notably, abstract number 4511 was selected for an oral presentation as part of a Poster Discussion Session.   Abstract Title: A Phase 1b/2 study of batiraxcept (AVB-S6-500) in combination with cabozantinib in patients with advanced or metastatic clear cell renal cell (ccRCC) carcinoma who have received front-line treatment (NCT04300140)Abstract Number: 4511 (Poster Discussion Session – Data will be presented)Poster Session: Genitourinary Cancer—Kidney...

STAMFORD, Conn., April 29, 2022 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 9, 2022, at 4:30 p.m. ET to report first quarter 2022 financial results and provide a corporate update. To participate in the conference call, please dial (855) 445-2816 (domestic) or (484) 756-4300 (international) and refer to conference ID 9296276. A live webcast of the call can be accessed under “Events & Presentations” in the News & Investors section of the Company’s website at www.CaraTherapeutics.com. An archived webcast recording will be available on the Cara website beginning approximately...

QAPs Supporting Molecular Diagnostic Tests for Dominant COVID-variant MISSISSAUGA, Ontario, April 29, 2022 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it will present performance results of its Quality Assessment Products (“QAPs™”) supporting molecular-diagnostic tests for the Omicron variant of the SARS-CoV-2 virus (“Omicron”) at the 2022 Clinical Virology Symposium of the American Society for Microbiology (“CVS”) taking place in West Palm Beach, Florida from May 1-4, 2022. At CVS, Microbix will be exhibiting alongside leading diagnostics firms that provide tests for detection of COVID and other infectious diseases. Microbix will also review performance of its QAPs to support quality management of testing for infection with Omicron...

DENVER, April 29, 2022 (GLOBE NEWSWIRE) — The Simply Good Foods Company (NASDAQ:SMPL) (“Simply Good Foods” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today announced that members of the executive management team will participate in a fireside chat at the Goldman Sachs Staples Forum on Tuesday, May 17, 2022 at 8:55 a.m. ET. The live audio webcast will be available at https://www.thesimplygoodfoodscompany.com within the Events and Presentations section of the Company’s website. About The Simply Good Foods CompanyThe Simply Good Foods Company (Nasdaq: SMPL), headquartered in Denver, Colorado, is a highly-focused food company with a product portfolio consisting primarily of nutrition bars, ready-to-drink shakes, sweet and salty snacks and confectionery products marketed under...

Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22 Announces second quarter 2022 financial guidance Increases full-year 2022 financial guidanceWINTER SPRINGS, Fla., April 29, 2022 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), announced today its financial results for the three months ended March 31, 2022. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures. “I am very satisfied with these results. Having the first quarter start off strongly shows the continued strength of our business. Our growth...